Phathom Pharmaceuticals, Inc. (PHAT)

NASDAQ: PHAT · Real-Time Price · USD

11.20

+0.66 (6.26%)

At close: Jul 2, 2026, 4:00 PM EDT

10.61

-0.59 (-5.29%)

After-hours: Jul 2, 2026, 7:00 PM EDT

Phathom Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	180.9	129.97	297.26	381.39	155.39	183.26
Cash & Short-Term Investments	180.9	129.97	297.26	381.39	155.39	183.26
Cash Growth	-14.79%	-56.28%	-22.06%	145.45%	-15.21%	-36.26%
Accounts Receivable	80.72	78.13	38.8	1.64	-	-
Inventory	6.51	5.52	3.21	1.21	-	-
Other Current Assets	8.44	15.35	20.87	13.19	5.13	3.27
Total Current Assets	276.57	228.97	360.13	397.43	160.51	186.53
Net Property, Plant & Equipment	3.52	3.67	2.09	3.62	3.49	2.56
Other Long-Term Assets	25.03	26.51	16.1	12.79	0.8	0.34
Total Assets	305.12	259.15	378.32	413.84	164.81	189.43
Accounts Payable	6.37	4.98	10.51	12.6	10	5.15
Accrued Expenses	84.99	91.66	54.94	18.34	15.53	13.28
Current Portion of Leases	0.67	0.65	0.5	0.73	0.71	0.49
Other Current Liabilities	33.02	34.75	19.78	7.11	-	-
Total Current Liabilities	125.04	132.04	85.73	38.78	26.24	18.92
Long-Term Debt	163.68	209.09	201.41	137.84	95.26	89.67
Long-Term Leases	1.96	2.07	-	0.46	1.1	1.18
Other Long-Term Liabilities	351.4	354.12	344.76	309.52	117.03	7.5
Total Long-Term Liabilities	517.03	565.27	546.17	447.82	213.39	98.35
Total Liabilities	642.08	697.32	631.9	486.6	239.62	117.28
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-in Capital	1,178	1,046	1,009	855.92	652.28	601.52
Retained Earnings	-1,515	-1,484	-1,263	-928.69	-727.09	-529.37
Shareholders' Equity	-336.96	-438.17	-253.58	-72.76	-74.81	72.16
Total Liabilities & Equity	305.12	259.15	378.32	413.84	164.81	189.43
Total Debt	166.3	211.8	201.91	139.03	97.07	91.34
Net Cash (Debt)	14.6	-81.83	95.35	242.36	58.32	91.92
Net Cash Growth	-	-	-60.66%	315.61%	-36.56%	-61.46%
Net Cash Per Share	0.19	-1.12	1.51	4.72	1.49	2.48
Book Value	-336.96	-438.17	-253.58	-72.76	-74.81	72.16
Book Value Per Share	-4.47	-6.01	-4.01	-1.42	-1.91	1.95
Tangible Book Value	-336.96	-438.17	-253.58	-72.76	-74.81	72.16
Tangible Book Value Per Share	-4.47	-6.01	-4.01	-1.42	-1.91	1.95

SEC Filings: 10-K · 10-Q